Abstract A058: Simultaneous characterization of rare immune cell subpopulations and PD-L1-expressing CTCs in peripheral blood of cancer patients
Sign Up to like & getrecommendations! Published in 2018 at "Biomarkers"
DOI: 10.1158/1535-7163.targ-17-a058
Abstract: Background: Expression of PD-L1 on tumor and immune markers in tumor tissueis associated with improved response to PD-1 and PD-L1 checkpoint inhibitors. However, the PD-L1 biomarker has limited predictive utility. Multimodal characterization of both tumor… read more here.
Keywords: rare immune; blood; cancer; cancer patients ... See more keywords
Multiple high-grade and rare immune-related adverse events in a colon cancer patient with genomic and cytokine profiling.
Sign Up to like & getrecommendations! Published in 2022 at "Immunotherapy"
DOI: 10.2217/imt-2021-0298
Abstract: We report a case of multiple high-grade and rare immune-related adverse events (irAEs) in a patient with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC). A middle-aged MSI-H mCRC patient with metastases to the lungs and… read more here.
Keywords: grade rare; high grade; grade; rare immune ... See more keywords